Exciting Advances in Waldenström Macroglobulinemia (WM) Treatment

Link to Full Transcript: bit.ly/3OhwItP
What new therapies are on the horizon for patients with Waldenström macroglobulinemia (WM)? Dr. Shayna Sarosiek from Dana-Farber Cancer Institute reviews promising developments in WM treatment, including immunotherapy and BTK inhibitors.
Dr. Shayna Sarosiek is a hematologist and oncologist at the Dana-Farber Cancer Institute where she cares for Waldenström macroglobulinemia (WM) patients at the Bing Center for Waldenstrom’s. Dr. Sarsosiek is also Assistant Professor of Medicine at Harvard Medical School.
Learn more about Dr. Sarosiek, here: www.dana-farber.org/find-a-do....